RU58841 5%

RU58841 5%

€0,00
Skip to product information
RU58841 5%
Research Formulation • Topical Delivery System

RU58841 5%

Topical Research Solution
CAS No. 154992-24-2
Format 5% w/v
Volume 50 mL
Access request-only

Single-compound, solvent-based topical research formulation developed for localized, non-clinical androgen receptor interaction studies.

Submit Formulation Request

Prefer email communication?
Request this formulation via our consultation form.

Request-only supply. No instant checkout. All formulation requests are reviewed before fulfilment.

Technical Data
Chemical Identification
Chemical Name4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
SynonymsRU58841
RU 58841
PSK-3841
HMR-3841
Molecular FormulaC17H18F3N3O3
Molecular Weight369.34 g/mol
Compound ClassNon-steroidal antiandrogen / androgen receptor antagonist
Purity≥98%
InChIKeyARBYGDBJECGMGA-UHFFFAOYSA-N
Physicochemical Characteristics
AppearanceClear to slightly opalescent, colorless to faint yellow solution.
Formulation TypeTopical Solution
Delivery SystemSolvent-based topical formulation
Solubility ContextMulti-solvent carrier architecture utilized to support a stable 5% w/v RU58841 concentration.
Water ContentNo added water. Water-free system selected to support compound integrity and reduce crystallization risk.
StorageStore tightly closed in a cool, dry, dark environment.
StabilityStability may vary depending on exposure to heat, light, oxygen, and prolonged environmental stress.
Documentation & Analytical Data
Analytical StandardResearch-grade analytical reference
Research ClassificationNon-clinical research formulation
Laboratory StatusResearch-use material
Batch DocumentationInternal batch documentation and formulation records maintained for research traceability purposes.
Documentation AvailabilityCOA / SDS / Batch Records available upon request depending on batch and formulation configuration.
TraceabilityBatch-level internal reference architecture maintained for controlled formulation tracking.
Research Documentation
Formulation Specification

Concentration system: 5% w/v

Equivalent concentration: 50 mg/mL

Total active content: 2.5 g per 50 mL

Vehicle system: Ethanol 96% (Ph. Eur.) / Propylene Glycol (Ph. Eur.) / Diethylene Glycol Monoethyl Ether — Transcutol® P (Ph. Eur.)

Solvent ratio: 65 / 15 / 20

Formulation architecture: Multi-solvent topical carrier system designed to support compound solubility, formulation consistency, and controlled surface application modeling.

Water content: No added water

Formulation complexity: Single-compound system

Research Context

RU58841 is a non-steroidal antiandrogen compound investigated in non-clinical research models involving localized androgen receptor interaction.

In topical research contexts, RU58841 is commonly evaluated as a surface-applied compound where localized delivery behavior, receptor-associated activity, and carrier-system compatibility are relevant experimental parameters.

This GeneTherica formulation is positioned as a research-grade topical solution for controlled, non-clinical laboratory use. It is not supplied for therapeutic, diagnostic, cosmetic, or human application.

Storage & Handling

Storage range: 2–8°C preferred; 15–25°C acceptable for short-term controlled handling.

Storage conditions: Store tightly closed in a cool, dry, dark environment.

Light sensitivity: Protect from direct sunlight and UV exposure.

Temperature stability: Avoid freezing and heat spikes. Freezing may induce crystallization behavior.

Air exposure: Minimize prolonged exposure to air.

Closure requirement: Keep container tightly sealed when not in use.

Stability context: Storage conditions are intended to support solvent balance, formulation consistency, and compound integrity during controlled non-clinical handling.

Research Use Notice

Supplied exclusively for laboratory research and analytical applications.

Not intended for therapeutic, cosmetic, veterinary, food, household, diagnostic, or human application.

Handling should occur within qualified non-clinical research environments only.

Vehicle System
Multi-Solvent Carrier Architecture
Ethanol 96% Ph. Eur.
Propylene Glycol Ph. Eur.
Transcutol® P Ph. Eur.
Solvent Ratio 65 / 15 / 20
Research Use Notice
GeneTherica products are supplied for research use only. Products are not medicines, cosmetics, or approved therapeutic agents. Information provided is for technical and research-context identification only and does not constitute medical, clinical, or treatment guidance.
Documentation Availability
COA / SDS / Batch Records
Available upon request depending on batch and formulation configuration.
Research-Grade Quality
Manufactured under defined quality standards for consistent research performance.
Topical Delivery System
Solvent-based formulation designed for localized and targeted research applications.
Transparency
Full documentation and traceability for every research batch.
Secure & Confidential
Your research and inquiries are handled with complete confidentiality.

Overview

RU58841 is a non-steroidal anti-androgen compound investigated within controlled research environments for its localized interaction with androgen receptors at the tissue level.

Within topical research frameworks, RU58841 formulations are primarily examined for their ability to modulate localized androgen receptor activity without intended systemic hormonal involvement.

Experimental focus is generally directed toward receptor-level signaling behavior and localized biological response pathways associated with androgen activity in surface-confined application environments.

Research applications focus on surface-confined delivery systems designed to limit activity to the application area, supporting investigation into localized tissue interactions.

This formulation is presented as a research-grade topical solution intended exclusively for scientific, analytical, and laboratory-based use under appropriate controlled handling conditions.

Laboratory liquid surface
Scientific liquid wave
Laboratory glassware
GeneTherica Documentation Infrastructure

Research Documentation & Technical Systems

Documentation architecture associated with the RU58841 topical research system, including batch-level analytical reference, solvent-system infrastructure, physicochemical handling orientation, and controlled safety documentation access.
Research Infrastructure
Technical Documentation Layer
GeneTherica documentation systems are structured around controlled formulation architecture, analytical reference context, solvent-system engineering, and batch-oriented research documentation.
Research Overview →
Physicochemical Orientation
Documentation emphasizes solvent compatibility, evaporation behavior, crystallization prevention, and controlled carrier architecture.
Batch-Level Structure
Technical references may include batch identifiers, analytical specification context, and raw material traceability layers.
Research Context
Documentation infrastructure is intended for controlled non-clinical research orientation and laboratory identification purposes.
Controlled Systems
Access to certain documentation layers may depend on compound configuration, formulation type, and request evaluation.